OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The microbial metabolome in metabolic‐associated fatty liver disease
Mengci Li, Cynthia Rajani, Xiaojiao Zheng, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 37, Iss. 1, pp. 15-23
Open Access | Times Cited: 13
Mengci Li, Cynthia Rajani, Xiaojiao Zheng, et al.
Journal of Gastroenterology and Hepatology (2021) Vol. 37, Iss. 1, pp. 15-23
Open Access | Times Cited: 13
Showing 13 citing articles:
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 32
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 32
Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism
Jieyi Wang, Dan Zheng, Fengjie Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Jieyi Wang, Dan Zheng, Fengjie Huang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 16-36
Open Access | Times Cited: 12
Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 16-36
Open Access | Times Cited: 12
In vitro dynamics of rumen microbiota and fermentation profiles with Antler growth of Sika deer
Songze Li, Shaoying Wang, Yuhang Zhu, et al.
Microbiology Spectrum (2025)
Open Access
Songze Li, Shaoying Wang, Yuhang Zhu, et al.
Microbiology Spectrum (2025)
Open Access
Dysbiosis of the Gut Micro-flora Aggravates Symptoms and Accelerates Disease Progression in MASLD-IBD Co-morbid Mice through Host-Microbial Metabolic Imbalance
Minling Lin, Ruiting Huang, Wanyu Li, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 769, pp. 110441-110441
Closed Access
Minling Lin, Ruiting Huang, Wanyu Li, et al.
Archives of Biochemistry and Biophysics (2025) Vol. 769, pp. 110441-110441
Closed Access
CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
Haize Ge, Wei Wei, Liang Tang, et al.
Medicine (2022) Vol. 101, Iss. 25, pp. e29347-e29347
Open Access | Times Cited: 12
Haize Ge, Wei Wei, Liang Tang, et al.
Medicine (2022) Vol. 101, Iss. 25, pp. e29347-e29347
Open Access | Times Cited: 12
Metabolic alterations of the gut–liver axis induced by cholic acid contribute to hepatic steatosis in rats
Hongxia Liu, Fumika Yokoyama, Satoshi Ishizuka
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 7, pp. 159319-159319
Open Access | Times Cited: 6
Hongxia Liu, Fumika Yokoyama, Satoshi Ishizuka
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2023) Vol. 1868, Iss. 7, pp. 159319-159319
Open Access | Times Cited: 6
Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link
Jayavardhan Vulchi, Varun Suryadevara, Pazhanivel Mohan, et al.
Journal of Translational Gastroenterology (2023) Vol. 1, Iss. 2, pp. 74-86
Open Access | Times Cited: 6
Jayavardhan Vulchi, Varun Suryadevara, Pazhanivel Mohan, et al.
Journal of Translational Gastroenterology (2023) Vol. 1, Iss. 2, pp. 74-86
Open Access | Times Cited: 6
Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access | Times Cited: 2
Liangtao Zhao, Haolan Tang, Zhangjun Cheng
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1724-1724
Open Access | Times Cited: 2
Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level
Haruki Uojima, Yoshihiko Sakaguchi, Kazuyoshi Gotoh, et al.
Digestive Diseases (2023) Vol. 42, Iss. 1, pp. 61-69
Open Access | Times Cited: 1
Haruki Uojima, Yoshihiko Sakaguchi, Kazuyoshi Gotoh, et al.
Digestive Diseases (2023) Vol. 42, Iss. 1, pp. 61-69
Open Access | Times Cited: 1
A cross‐omics data analysis strategy for metabolite‐microbe pair identification
Tao Sun, Dongnan Sun, Junliang Kuang, et al.
PROTEOMICS (2024) Vol. 24, Iss. 21-22
Closed Access
Tao Sun, Dongnan Sun, Junliang Kuang, et al.
PROTEOMICS (2024) Vol. 24, Iss. 21-22
Closed Access
The functional role and translational potential of gut microbiota and microbial metabolites in liver diseases
Jun Yu
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 1, pp. 5-6
Open Access | Times Cited: 1
Jun Yu
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 1, pp. 5-6
Open Access | Times Cited: 1
Efficacy of Gegenqinlian Xiezhuo Decoction in the Treatment of Non-alcoholic Fatty Liver of Spleen Deficiency and Blood Stasis Syndrome
Xiaoqian Wang, Huaizhen Liu
Journal of Contemporary Medical Practice (2022) Vol. 4, Iss. 1
Open Access
Xiaoqian Wang, Huaizhen Liu
Journal of Contemporary Medical Practice (2022) Vol. 4, Iss. 1
Open Access
